Vistagen Therapeutics Balance Sheet (2011-2025) | VTGN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Accumulated Depreciation (Quarter)
Receivables - Accured (Quarter)
Assets
Current Assets
Cash & Equivalents (Quarter)	103.11M	97.80M	93.60M	83.70M	68.14M	51.99M	35.29M	25.04M	16.64M	9.60M	37.61M	126.56M	119.17M	102.92M	84.25M	74.72M	67.13M	48.98M	62.79M	47.37M
Receivables - Net (Quarter)	0.04M
Receivables - Other (Quarter)	0.04M	0.04M			0.20M				0.28M	0.38M	0.24M	0.22M	0.20M	0.19M	0.17M	0.15M	0.13M	0.11M	0.09M	0.07M
Receivables (Quarter)	0.08M
Prepaid Assets (Quarter)	0.88M	1.87M	2.68M	2.94M	2.75M	2.89M	1.56M	0.95M	0.80M	1.89M	1.39M	1.48M	1.51M	2.47M	2.37M	1.38M	1.59M	3.54M	1.76M	1.48M
Current Deferred Tax Assets (Quarter)	0.13M	0.13M	0.13M	0.13M	0.12M	0.12M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M
Current Assets (Quarter)	104.12M	99.83M	96.44M	86.77M	71.00M	54.99M	36.91M	26.06M	17.51M	11.58M	39.08M	128.11M	120.67M	110.84M	99.95M	89.94M	82.08M	66.72M	78.93M	63.24M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.37M	0.48M	0.50M	0.45M	0.41M	0.57M	0.56M	0.54M	0.51M	0.48M	0.44M	0.45M	0.43M	0.49M	0.47M	0.43M	0.48M	0.53M	0.52M	0.48M
Intangibles (Quarter)
Goodwill & Intangibles (Quarter)
Other Non-Current Assets (Quarter)	0.23M	0.20M	0.05M	0.10M	0.15M	0.10M	0.25M	0.10M	0.10M	0.10M	0.10M	0.15M	0.73M	0.52M	0.50M	0.48M	0.45M	0.47M	0.41M	0.39M
Non-Current Assets (Quarter)	4.16M	4.08M	4.06M	3.77M	3.65M	3.73M	3.79M	3.65M	3.58M	3.45M	3.12M	2.95M	2.98M	2.71M	2.55M	2.37M	2.27M	2.21M	2.00M	1.81M
Assets (Quarter)	108.28M	103.91M	100.50M	90.54M	74.64M	58.73M	40.70M	29.71M	21.09M	15.03M	42.20M	131.07M	123.65M	113.55M	102.50M	92.31M	84.34M	68.92M	80.93M	65.06M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.84M	2.32M	2.66M	0.00M	2.76M	0.01M	2.96M	1.60M	2.47M	1.62M	1.30M	1.74M	1.55M	1.21M	0.71M	1.04M	0.65M	0.49M	1.83M	1.28M
Notes Payables (Quarter)						1.04M	0.73M	0.42M	0.10M	0.78M								0.93M	0.66M	0.40M
Payables (Quarter)	0.84M	2.32M	2.66M	0.00M	2.76M	1.05M	3.69M	2.02M	2.58M	2.41M	1.30M	1.74M	1.55M	1.21M	0.71M	1.04M	0.65M	1.42M	2.49M	1.68M
Accumulated Expenses (Quarter)		2.15M	1.99M	2.63M	0.07M	0.24M	1.19M	0.31M	0.80M	0.04M	0.29M	0.13M	2.23M	2.16M	3.81M	5.47M	8.81M	6.58M	8.42M	9.25M
Other Accumulated Expenses (Quarter)	0.03M		0.06M		0.03M	0.01M	0.00M			0.01M
Short term Debt (Quarter)
Current Leases (Quarter)	0.36M	0.38M	0.40M	300.00		0.00M	0.00M	0.47M	0.49M	0.00M	0.52M	0.53M	0.55M	0.57M	0.53M	0.60M	0.56M	0.64M	0.60M	0.62M
Current Deferred Revenue (Quarter)	1.42M	1.42M	1.42M	1.42M	2.80M	1.24M	0.71M	0.71M	0.71M	0.71M	0.79M	1.76M	0.79M	2.30M	2.47M	2.51M	2.59M	2.51M	2.14M	2.00M
Total Current Liabilities (Quarter)	4.19M	6.27M	7.91M	6.42M	5.77M	8.93M	6.05M	4.29M	4.57M	4.05M	2.91M	4.16M	5.12M	6.24M	7.52M	9.62M	12.61M	11.15M	13.64M	13.53M
Non-Current Liabilities
Capital Leases (Quarter)						0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)	2.49M	2.14M	0.32M	0.28M	0.32M	0.38M	0.41M	2.49M	0.50M	2.14M	1.78M	0.33M	2.67M	1.09M	0.73M	0.45M	0.39M	0.22M	0.34M	0.18M
Operating Leases (Quarter)	3.35M	3.63M	3.14M	2.72M	2.61M	2.49M	2.37M	2.25M	2.12M	1.99M	1.85M	1.71M	1.57M	1.42M	1.27M	1.11M	0.95M	0.78M	0.61M	0.43M
Other Non-Current Liabilities (Quarter)
Total Non-Current Liabilities (Quarter)	12.11M	12.02M	11.93M	4.14M	4.16M	3.75M	5.05M	4.75M	4.44M	4.13M	3.64M
Total Liabilities (Quarter)	16.30M	18.29M	19.84M	10.56M	9.93M	12.67M	11.10M	9.03M	9.01M	8.18M	6.55M	7.78M	9.37M	8.74M	9.52M	11.19M	13.95M	12.16M	14.59M	14.14M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	91.98M	85.62M	80.66M	79.98M	64.72M	46.05M	29.61M	20.67M	12.08M	6.85M	35.65M	123.28M	114.29M	104.80M	92.97M	81.12M	70.39M	56.77M	66.34M	50.92M
Shareholder's Equity (Quarter)	91.98M	85.62M	80.66M	79.98M	64.72M	46.05M	29.61M	20.67M	12.08M	6.85M	35.65M	123.28M	114.29M	104.80M	92.97M	81.12M	70.39M	56.77M	66.34M	50.92M
Liabilities and Shareholders Equity (Quarter)	108.28M	103.91M	100.50M	90.54M	74.64M	58.73M	40.70M	29.71M	21.09M	15.03M	42.20M	131.07M	123.65M	113.55M	102.50M	92.31M	84.34M	68.92M	80.93M	65.06M
Treasury Shares (Quarter)	0.14M	0.14M	0.14M	0.14M	0.00M	0.14M	0.14M	0.14M	0.00M	0.00M	0.00M		0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Retained Earnings (Quarter)	-219.84M	-227.59M	-240.40M	-250.92M	-267.60M	-287.38M	-304.86M	-314.62M	-326.85M	-333.80M	-340.34M	-346.69M	-356.21M	-366.95M	0.02M	-394.00M	-407.63M	0.00M	0.01M	-461.04M
Preferred Shares (Quarter)	0.00M	0.00M
Shares Outstanding (Quarter)	1.13M	2.32M	2.32M	206.64M	6.89M	6.90M	6.90M	6.90M	7.32M	7.88M	12.02M	27.03M	27.03M	27.06M	27.06M	28.32M	29.00M	29.29M	38.90M	39.62M

Research Tools

Vistagen Therapeutics Balance Sheet (2011-2025) | VTGN

Create an account

Sign In

Reset Password